Oxidative stress and hepatocarcinogenesis

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. There are two major challenges for HCC, the first being that early detection is generally not applicable, and secondly, it is usually fatal within several months after diagnosis. HCC is an inflammation-induced cancer. It is known that chronic inflammation leads to oxidative/nitrosative stress and lipid peroxidation, generating excess oxidative stress, together with aldehydes which can react with DNA bases to form promutagenic DNA adducts. In this review, the evidence between oxidative stress and liver carcinogenesis is summarized. We focused on the potential of using DNA adducts as oxidative stress biomarkers for liver carcinogenesis.

Keywords

Oxidative stress / DNA adduct / hepatocellular carcinoma / prevention / hepatocarcinogenesis

References

[1] Reig M,Perello C,Ribeiro A,Diaz A,Darnell A,Sangro B,Forns X.Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.J Hepatol2016;65:719-26

[2] Lencioni R,Han G,Yang J,Paik SW,Kim DY,Luca A,Leberre MA,Nicholson K,Bruix J.Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial.J Hepatol2016;64:1090-8

[3] Hoffmann K,Radeleff B,Heining C,Zahlten-Hinguranage A,Schmidt J,Jaeger D,Schemmer P.Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]..BMC Cancer2008;8:349 PMCID:PMC2630329

[4] Wang FS,Zhang Z,Wang HY.The global burden of liver disease: the major impact of China.Hepatology2014;60:2099-108 PMCID:PMC4867229

[5] Rahib L,Aizenberg R,Fleshman JM.Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Res2014;74:2913-21

[6] Ryerson AB,Altekruse SF,Jemal A,Henley SJ,Lake A,Anderson RN,Ly KN,Penberthy L.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Cancer2016;122:1312-37 PMCID:PMC4840031

[7] Camma C,Craxi A.Direct antiviral agents and risk for HCC early recurrence: much ado about nothing.J Hepatol2016;65:861-2

[8] Umemura A,Taniguchi K,Yamachika S,Zhong Z,Raghunandan S,Linares JF,Umemura S,Seki E,Koike K,Diaz-Meco MT,Karin M.p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells.Cancer Cell2016;29:935-48 PMCID:PMC4907799

[9] Ozer Etik D,Boyacioglu AS.Management of hepatocellular carcinoma: prevention, surveillance, diagnosis, and staging.Exp Clin Transplant2017;15:31-5

[10] Oishi N,Kaneko S.Molecular biology of liver cancer stem cells.Liver Cancer2014;3:71-84 PMCID:PMC4057789

[11] Xue W,Yin H,Papagiannakopoulos T,Cai W,Bronson R,Zhang F,Sharp PA.CRISPR-mediated direct mutation of cancer genes in the mouse liver.Nature2014;514:380-4 PMCID:PMC4199937

[12] Eggert T,Ji J,Yevsa T,Medina-Echeverz J,Forgues M,Heikenwalder M,Zender L.Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression.Cancer Cell2016;30:533-47

[13] Jang JW,Bae SH,Yoon SK,Yang JM,Lee CD,Chung KW.Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.J Hepatol2004;41:427-35

[14] Yoon SK,Ha SA,Choi JY,Sun HS,Chung J,Kim JW.The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.Cancer Res2004;64:5434-41

[15] Zinkin NT,Bhaskar K,Spentzos D,Wells M,Asara JM,Afdhal NH.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.Clin Cancer Res2008;14:470-7

[16] Ji JF,Budhu A,Forgues M,Ambs S,Meltzer PS,Qin LX,Lo CM,Ng IO,Tang ZY,Wang XW.MicroRNA expression, survival, and response to interferon in liver cancer.N Engl J Med2009;361:1437-47 PMCID:PMC2786938

[17] Jia HL,Qin LX,Forgues M,Liu YK,Wang L,Shen F,Wang XW.Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.Clin Cancer Res2007;13:1133-9

[18] Beale G,Gray J,Hudson M,Trerotoli P,Manas D.AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.BMC Cancer2008;8:200 PMCID:PMC2488355

[19] Li LM,Zhou ZX,Liu FY,Shen HB,Zen K.Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.Cancer Res2010;70:9798-807

[20] Labgaa I.Liquid biopsy in liver cancer.Discov Med2015;19:263-73

[21] Yang JD.Hepatocellular carcinoma: a global view.Nat Rev Gastroenterol Hepatol2010;7:448-58 PMCID:PMC3926946

[22] Starley BQ,Harrison SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.Hepatology2010;51:1820-32

[23] Ande SR,Gregoire Nyomba BL.Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC.Sci Rep2016;6:23608 PMCID:PMC4804274

[24] Shalapour S.Fatty acid-induced T cell loss greases liver carcinogenesis.Cell Metab2016;23:759-61

[25] Galun E.Liver inflammation and cancer: the role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma.Hepatology2016;63:159-68

[26] He G.NF-κB and STAT3-key players in liver inflammation and cancer.Cell Res2011;21:354-6 PMCID:PMC3193410

[27] Qiao L.Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now.Cancer Lett2014;345:150-2

[28] Bishayee A.The role of inflammation in liver cancer.Adv Exp Med Biol2014;816:401-35

[29] Nikolaou K,Talianidis I.Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer.Clin Cancer Res2013;19:2810-6

[30] Bartsch H.Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair.Langenbecks Arch Surg2006;391:499-510

[31] Kensler TW.Role of oxygen radicals in tumor promotion.Environ Mutagen1984;6:593-616

[32] Marra M,Lombardi A,Tarantino L,Stiuso P,Sperlongano R,Agresti M,Sperlongano P.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.J Transl Med2011;9:171 PMCID:PMC3213217

[33] Caldwell SH,Kang HS.Obesity and hepatocellular carcinoma.Gastroenterology2004;127:S97-103

[34] Matsuzawa-Nagata N,Ando H,Kurita S,Ota T,Honda M,Kaneko S.Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity.Metabolism2008;57:1071-7

[35] Furukawa S,Shimabukuro M,Yamada Y,Nakayama O,Matsuda M.Increased oxidative stress in obesity and its impact on metabolic syndrome.J Clin Invest2004;114:1752-61 PMCID:PMC535065

[36] Steinmetz KA.Vegetables, fruit, and cancer prevention: a review.J Am Diet Assoc1996;96:1027-39

[37] Block G,Subar A.Fruit, vegetables, and cancer prevention - a review of the epidemiologic evidence.Nutr Cancer1992;18:1-29

[38] Halliwell B.Oxidative stress and cancer: have we moved forward?.Biochem J2007;401:1-11

[39] Xu Z,Leung L,Lee C.Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia.Proc Natl Acad Sci U S A2005;102:4120-5 PMCID:PMC554825

[40] Ko C,Berger J,Brandhagen D,Cotler SJ,McCashland TM,Gordon FD,Kowdley KV.Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.Liver Int2007;27:1394-401

[41] Marrogi AJ,van Gijssel HE,Rahim H,Kowdley KV,Nair J,Okby N,Ishak KG.Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma.J Natl Cancer Inst2001;93:1652-5

[42] Houglum K,Witztum JL.Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.J Clin Invest1990;86:1991-8 PMCID:PMC329836

[43] Hu W,Eveleigh J,Pan J,Chung FL.The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma.Carcinogenesis2002;23:1781-9

[44] Hussain SP,Amstad PA,Trudel LJ,Hofseth LJ,Billiar TR,Hohler T,Phillips DH,Marrogi AJ.Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.Proc Natl Acad Sci U S A2000;97:12770-5 PMCID:PMC18839

[45] Vautier G,Portmann BC,Williams R.p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis.Gastroenterology1999;117:154-60

[46] Wang XW,Huo TI,Forgues M,Brechot C.Molecular pathogenesis of human hepatocellular carcinoma.Toxicology2002;181-182:43-7

[47] Tanaka S,Yasen M,Noguchi N,Kudo A,Tanaka H,Kokudo N,Kawasaki S,Arii S.Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study.Hepatology2011;54:1273-81

[48] Sasaki Y.Does oxidative stress participate in the development of hepatocellular carcinoma?.J Gastroenterol2006;41:1135-48

[49] Paradies G,Ruggiero FM.Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.World J Gastroenterol2014;20:14205-18 PMCID:PMC4202349

[50] Gentric G,Paradis V,L'Hermitte A,Fromenty B,Desdouets C.Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.J Clin Invest2015;125:981-92 PMCID:PMC4362240

[51] Satapati S,Duarte JA,Reynolds L,He T,Livingston KA,Merritt ME,Malloy CR,Lambert J,Corbin I,Browning JD.Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.J Clin Invest2015;125:4447-62 PMCID:PMC4665800

[52] Cichoz-Lach H.Oxidative stress as a crucial factor in liver diseases.World J Gastroenterol2014;20:8082-91 PMCID:PMC4081679

[53] Polimeni L,Baratta F,Albanese F,Violi F.Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis.World J Hepatol2015;7:1325-36 PMCID:PMC4450196

[54] Meyskens FL,McNulty SE.Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress.Clin Cancer Res1999;5:1197-202

[55] Brown NS.Hypoxia and oxidative stress in breast cancer.Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res2001;3:323-7 PMCID:PMC138696

[56] Toyokuni S,Yodoi J.Persistent oxidative stress in cancer.FEBS Lett1995;358:1-3

[57] Suzuki Y,Takai K,Hayashi H,Nishigaki Y,Shimizu M.Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.J Cancer Res Clin Oncol2013;139:845-52

[58] Jungst C,Gehrke R,Nischalke HD,Schramel P,Sauerbruch T.Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma.Hepatology2004;39:1663-72

[59] Maki A,Gupta M,Suzuki T,Fujii H.Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.Ann Surg Oncol2007;14:1182-90

[60] Bartsch H.Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis.Cancer Detect Prev2004;28:385-91

[61] Nair U,Nair J.Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.Free Radic Biol Med2007;43:1109-20

[62] Fu Y,Dyba M,Pondicherry SR,Schultz CL,Pan J,Krzeminski J,Christov PP,Chung FL.In vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.Free Radic Biol Med2014;73:12-20 PMCID:PMC4114339

[63] Choudhury S,Amin S,Roy R.Repair kinetics of trans-4-hydroxynonenal-induced cyclic 1,N(2)-propanodeoxyguanine DNA adducts by human cell nuclear extracts.Biochemistry2004;43:7514-21 PMCID:PMC2711554

[64] Pan JS,Xuan Z,Wang HT,Greenspan E,Creswell K,Berry D,Chung FL.Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies.Chem Res Toxicol2012;25:2788-95 PMCID:PMC3561715

[65] Jia L,Harris CC.Hepatitis B virus X protein inhibits nucleotide excision repair.Int J Cancer1999;80:875-9

[66] Nath RG.Detection of exocyclic 1,N-2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans.Proc Natl Acad Sci U S A1994;91:7491-5

[67] Feng ZH,Hu Y.Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair.Proc Natl Acad Sci U S A2006;103:15404-9 PMCID:PMC1592536

[68] Liu XY,Xie JP.Mutagenicity of acrolein and acrolein-induced DNA adducts.Toxicol Mech Methods2010;20:36-44

[69] Yang IY,Miller H,Torres MC,Moriya M.Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells.Biochemistry2002;41:13826-32

[70] VanderVeen LA,Nechev LV,Harris CM.Evaluation of the mutagenic potential of the principal DNA adduct of acrolein.J Biol Chem2001;276:9066-70

[71] Fu Y,McCutcheon JN,Nath RG,Coia H,Pan J,Kallakury B,Zhang YW,He AR.An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.Hepatology2018;67:159-70

[72] Yang JD.Green tea consumption: a potential chemopreventive measure for hepatocellular carcinoma?.Hepatology2018;67:10-2

[73] Arbuthnot P,Kew M.Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.J Gastroenterol Hepatol2000;15:357-68

[74] Kudo M.Adjuvant therapy after curative treatment for hepatocellular carcinoma.Oncology2011;81:50-5

[75] Schwartz JD,Mandeli J.Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.Lancet Oncol2002;3:593-603

[76] Poon RT.Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.Hepatology2011;54:757-9

[77] Izumi N.Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma.Hepatol Res2012;42:226-32

[78] Mazzaferro V,Schiavo M,Camerini T,Capussotti L,Pellicci R,Tagger A,Bonino F,Llovet JM.Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.Hepatology2006;44:1543-54

[79] Wang SN,Lee KT.Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: a pilot study.Hepatol Res2014;44:523-31

[80] Yoshida H,Kudo M,Mizuta T,Yamamoto K,Saito K,Kawabe T,Kobashi H,Osaki Y,Izumi N,Tsuji K,Seki T,Masaki N,Seike M,Ueno Y,Kuromatsu R,Ikeda H,Kokuryu H,Sakaida I,Kikuchi K,Omata M.Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.Hepatology2011;54:532-40

[81] Yoshiji H,Toyohara M,Kitade M,Yamazaki M,Mitoro A,Yoshida M,Tsujimoto T,Uemura M.Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.J Hepatol2009;51:315-21

[82] Song CX,Lu XY,Dai Q,He C.Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine.Nat Methods2011;9:75-7 PMCID:PMC3646335

[83] Li S,Wang N,Lao L,Feng Y.The role of oxidative stress and antioxidants in liver diseases.Int J Mol Sci2015;16:26087-124 PMCID:PMC4661801

[84] Ganji SH,Kamanna VS.Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: impact on non-alcoholic fatty liver disease.Metabolism2015;64:982-90

[85] Xiao J,Liong EC,Leung TM,Fung ML.Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.Eur J Nutr2014;53:187-99